Journal article

Effects of corticotropin-releasing hormone on proopiomelanocortin derivatives and monocytic HLA-DR expression in patients with septic shock


Authors listMatejec, Reginald; Kayser, Friederike; Schmal, Frauke; Uhle, Florian; Boedeker, Rolf-Hasso; Maxeiner, Hagen; Kolbe, Julia Anna

Publication year2013

Pages133-141

JournalPeptides

Volume number47

ISSN0196-9781

DOI Linkhttps://doi.org/10.1016/j.peptides.2013.07.013

PublisherElsevier


Abstract
Little is known about interactions between immune and neuro-endocrine systems in patients with septic shock. We therefore evaluated whether the corticotropin-releasing hormone (CRH) and/or proopiomelanocortin (POMC) derivatives [ACTH, p-endorphin (p-END), p-lipotropin (beta-LPH), alpha-melanocyte stimulating hormone (alpha-MSH) or N-acetyl-beta-END (Nac-beta-END)] have any influences on monocyte deactivation as a major factor of immunosuppression under septic shock conditions. Sixteen patients with septic shock were enrolled in a double-blind, cross-over and placebo controlled clinical study; 0.5 mu g/(kg(bodyweight) h) CRH (or placebo) were intravenously administered for 24 h. Using flow cytometry we investigated the immunosuppression in patients as far as related to the loss of leukocyte surface antigen-DR expression on circulating monocytes (mHLA-DR). ACTH, beta-END immunoreacive material (IRM), beta-LPH IRM, alpha-MSH and Nac-beta-END IRM as well as TNF-alpha and mHLA-DR expression were determined before, during and after treatment with CRH (or placebo). A significant correlation between plasma concentration of ce.-MSH and mHLA-DR expression and an inverse correlation between mHLA-DR expression and TNF-alpha plasma level were found. Additionally, a significant increase of mHLA-DR expression was observed 16 h after starting the CRH infusion; 8 h later, the mHLA-DR expression had decreased again. Our results indicate that the up-regulation of mHLA-DR expression after CRH infusion is not dependent on the release of POMC derivatives. From the correlation between plasma concentration of alpha-MSH and mHLA-DR expression, we conclude that in patients with septic shock the down-regulation of mHAL-DR expression is accompanied by the loss of monocytic release of ce.-MSH into the cardiovascular compartment. (C) 2013 Elsevier Inc. All rights reserved.



Citation Styles

Harvard Citation styleMatejec, R., Kayser, F., Schmal, F., Uhle, F., Boedeker, R., Maxeiner, H., et al. (2013) Effects of corticotropin-releasing hormone on proopiomelanocortin derivatives and monocytic HLA-DR expression in patients with septic shock, Peptides, 47, pp. 133-141. https://doi.org/10.1016/j.peptides.2013.07.013

APA Citation styleMatejec, R., Kayser, F., Schmal, F., Uhle, F., Boedeker, R., Maxeiner, H., & Kolbe, J. (2013). Effects of corticotropin-releasing hormone on proopiomelanocortin derivatives and monocytic HLA-DR expression in patients with septic shock. Peptides. 47, 133-141. https://doi.org/10.1016/j.peptides.2013.07.013



Keywords


Alpha melanocyte stimulating hormone (alpha-MSH)BETA-ENDORPHINCorticotropin releasing hormone (CRH)Human leukocyte antigen-DR (HLA-DR)POSTOPERATIVE PAINProopiomelanocortin (POMC)SEPTIC SHOCKTumor necrosis factor-alpha (TNF-alpha)

Last updated on 2025-21-05 at 18:38